QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 p3-health-partners-affirms-fy2025-sales-guidance-of-1350b-1500b-vs-1435b-est

P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.350 billion-$1.500 billion to $1.350 billion-$1.500 billi...

 p3-health-partners-q2-eps-623-misses-411-estimate-sales-355788m-miss-358223m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.23) per share which missed the analyst consensus estimate of ...

 p3-health-partners-affirms-fy2025-sales-guidance-of-135b-150b-vs-141b-est

P3 Health Partners (NASDAQ:PIII) affirms FY2025 sales outlook from $1.35 billion-$1.50 billion to $1.35 billion-$1.50 billion v...

 p3-health-partners-q1-eps-628-up-from-786-yoy-sales-37323m-beat-36207m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(6.28) per share. This is a 20.1 percent increase over losses of...

 lake-street-maintains-buy-on-p3-health-partners-lowers-price-target-to-20

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from...

 medicare-advantage-rates-expected-to-climb-over-5-in-2026-easing-pressure-on-managed-care

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

 p3-health-partners-q4-2024-gaap-eps-036-misses-009-estimate-sales-370686m-miss-378056m-estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of ...

 p3-health-targeting-profitability-in-2025-with-initial-revenue-guidance-for-the-year-of-1350b-15b-and-adjusted-ebitda-of-35m-5m

Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30 millio...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION